EichorEICHOR
Location: York Synced from ClinicalTrials.gov · August 07, 2026

Clinical studies recruiting near York

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

Effects of Hip Bump Manipulation Versus Sham Treatment in Healthy Adults
NA · Dominican University New York · NCT07025434Symptoms and Functions in Patients With COPD and Chronic Bronchitis Switching From CIG to THS
NA · Panthera Biopartners · Philip Morris Products S.A. · NCT07108166A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients With Heart
Phase 3 · CON-11007 North York, ON Investigational Site · Colorado Prevention Center · NCT06024746Study of Efficacy and Safety of Iptacopan in Participants With IC-MPGN
Phase 3 · Col Uni Med Center New York Presby · Novartis Pharmaceuticals · NCT05755386ALLIANCE AVIV: Safety and Effectiveness of the SAPIEN X4 Transcatheter Heart Valve in Failing Aortic Bioprosthetic Valve
NA · Cornelll University New York · Edwards Lifesciences · NCT05172973Virtual Cycling Environments for Persons With Parkinson Disease
NA · Rutgers, The State University of New Jersey · NCT04804202A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line
Phase 3 · Cancer Care Associates Of York ( Site 0005) · Merck Sharp & Dohme LLC · NCT06136559Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
Phase 3 · The Blavatnik Family- Chelsea Medical Center at Mount Sinai · Merck Sharp & Dohme LLC · NCT06393374MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Wi
Phase 2 · Mount Sinai Hospital · National Cancer Institute (NCI) · NCT05564390A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) G
Phase 1/Phase 2 · Laura and Isaac Perlmutter Cancer Center at NYU Langone · National Cancer Institute (NCI) · NCT05099003Real-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe Atopic Dermatitis in Adolescents & Adults
Phase N/A · Galderma Investigational Site - 7051 · Galderma R&D · NCT06988605Single-Sided Deafness and Asymmetric Hearing Loss
NA · New York Eye and Ear Infirmary · Med-El Corporation · NCT04506853Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed
Phase 3 · Laura and Isaac Perlmutter Cancer Center at NYU Langone · National Cancer Institute (NCI) · NCT06172296CHIME: Comparing Health Interventions for Maternal Equity
NA · Columbia University Medical Center · Stanford University · NCT06724172Targeted Immunotherapy After Myeloablative TBI-Based Conditioning & AlloHCT in CAYA With High Risk T-Cell ALL & Lymphoma
Phase 1 · New York Medical College · NCT04972942A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine
Phase 3 · Fieve Clinical Research, Inc · Kallyope Inc. · NCT07674654Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small C
Phase 3 · New York Proton Center · NRG Oncology · NCT05624996PODOMOUNT-Basket, a Study to Test Whether BI 764198 Helps Adults and Adolescents With Different Types of Kidney Disease
Phase 2 · Boehringer Ingelheim · NCT07355296Hydration Intervention to Decrease Side Effects Associated With GLP - 1 RA Therapy
NA · State University of New York at Buffalo · NCT07641361Treatment With Endovascular Intervention for STroke Patients With Existing Disability
Phase N/A · Icahn School of Medicine at Mount Sinai · University of Cincinnati · NCT05911568A Longitudinal Multi-Center Molecular Biomarker Discovery Registry for Patients With Hematologic Malignancies
Phase N/A · Cancer Care Associates of York · Tempus AI · NCT07154823PRE-EMPT: Prospective RandomizEd Evaluation and Management of Premature aTherosclerosis
Phase 3 · New York University Langone · Duke University · NCT07232069A Study of Zasocitinib in Adults With Nonsegmental Vitiligo
Phase 2 · Mount Sinai · Takeda · NCT07108283Chronic Widespread Pain After Rapid Weight Loss in Non-Hispanic Black and Hispanic/Latino/a/x Adults
Phase N/A · NYU Steinhardt Arthur J. Nelson Laboratory · New York University · NCT06795386Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)
Phase 3 · Columbia University Irving Medical Center · PedAL BCU, LLC · NCT05183035A Study of Lower Radiotherapy Dose to Treat Children With CNS Germinoma
Phase 2 · Laura and Isaac Perlmutter Cancer Center at NYU Langone · Children's Oncology Group · NCT06368817A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma
Phase 2/Phase 3 · Laura and Isaac Perlmutter Cancer Center at NYU Langone · National Cancer Institute (NCI) · NCT05691478Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiov
Phase 3 · North York Diagnostic and Cardiac Centre · Amgen · NCT07037433Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer
Phase 1/Phase 2 · Icahn School of Medicine at Mount Sinai · Pfizer · NCT07421700Study of Intravenously (IV) Infused Etentamig in Combination With an Oral Cereblon E3 Ligase Modulatory Drug (CELMoD) Ag
Phase 1 · Memorial Sloan Kettering Cancer Center - New York - York Ave · AbbVie · NCT06896916
Look up another city
Look up another condition
Eichor
Clinical intelligence from public evidence
Use of Eichor is governed by our Terms of Use · Privacy Policy
© 2026 Biomedistats LLC (dba Eichor)

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.